Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07631546 · ClinicalTrials.gov registry record · NA
Investigating Behavior Change Methods for the Management of Hypertension
A NA study, sponsored by Texas A&M University.
- Active
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT07631546: Active NA study, sponsored by Texas A&M University.
NCT07631546 is a NA study that is active but no longer recruiting, run by Texas A&M University. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07631546, a NA study, is active but no longer recruiting, sponsored by Texas A&M University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This project aims to promote general wellness using a mobile health intervention that incorporates health coaching to help manage hypertension. The mobile application (HyperCoach) does not intend to cure, mitigate, or prevent hypertension. The main questions it aims to answer are: 1. Does digital mobile health coaching impact hypertension management outcomes, including blood pressure and adherence? 2. How does adherence to mobile health intervention influence the long-term man-agement and outcomes of hypertension? 3. How are health beliefs and QOL affected by digital coaching and health tracking for hypertension management? Participants will be required to complete the following: Blood pressure reading every day Weight reading every day Take hypertension medication as prescribed by their physician Complete educational content (if on coaching group) Belief and Attitudes Survey (before and after study) Personality Assessment Survey Demographic Information Survey Hypertension Health Literacy Survey (before and after study) Two General Health Literacy Surveys (before and after study) Quality of Life Survey
Primary Outcome
Blood pressure was measured by participants using a blood pressure cuff.
Interventions
- BEHAVIORAL Digital Coaching Plan
- BEHAVIORAL Health Awareness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-08-31 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT07631546 still lists
NCT07631546 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Digital Coaching Plan is the first listed.
NCT07631546 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07631546 about?
NCT07631546 is a clinical study titled "Investigating Behavior Change Methods for the Management of Hypertension". This project aims to promote general wellness using a mobile health intervention that incorporates health coaching to help manage hypertension. The mobile application (HyperCoach) does not intend to cure, mitigate, or prevent hypertension. The main questions it aims to answer are: 1. Does digital m...
What is the current status of trial NCT07631546?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 37 participants. The study started on 2023-08-31. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07631546?
The interventions under investigation include: Digital Coaching Plan (BEHAVIORAL), Health Awareness (BEHAVIORAL).
Who is sponsoring clinical trial NCT07631546?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07631546's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI